These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36618074)

  • 1. Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma.
    Liu J; Ma X; Cao L; Wei Y; Gao Y; Qu C; Maimaitiming N; Zhang L
    J Oncol; 2022; 2022():3658334. PubMed ID: 36618074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-Linked Kinase Is Involved In the Proliferation and Invasion of Esophageal Squamous Cell Carcinoma.
    Ning Z; Zhu X; Jiang Y; Gao A; Zou S; Gu C; He C; Chen Y; Ding WQ; Zhou J
    J Cancer; 2020; 11(2):324-333. PubMed ID: 31897228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathway.
    Xu T; Ma XL; Wei Y; Cao LY; Gao Y; Liu J; Zhang L
    Bioengineered; 2022 May; 13(5):12532-12547. PubMed ID: 35587162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia.
    Boulos JC; Chatterjee M; Shan L; Efferth T
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.
    Zhuang X; Lv M; Zhong Z; Zhang L; Jiang R; Chen J
    J Exp Clin Cancer Res; 2016 Aug; 35(1):130. PubMed ID: 27576342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 M
    Bharadwaj S; Azhar EI; Kamal MA; Bajrai LH; Dubey A; Jha K; Yadava U; Kang SG; Dwivedi VD
    J Biomol Struct Dyn; 2022 Apr; 40(6):2769-2784. PubMed ID: 33150855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma.
    Ma XL; Yao H; Wang X; Wei Y; Cao LY; Zhang Q; Zhang L
    Oncol Lett; 2019 Oct; 18(4):4114-4125. PubMed ID: 31579417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome.
    Yu J; Shi R; Zhang D; Wang E; Qiu X
    Virchows Arch; 2011 Jan; 458(1):99-107. PubMed ID: 21136077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase.
    Gulzar M; Syed SB; Khan FI; Khan P; Ali S; Hasan GM; Taneja P; Hassan MI
    Int J Biol Macromol; 2019 Feb; 122():1297-1304. PubMed ID: 30227205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells.
    Battista T; Pascarella G; Staid DS; Colotti G; Rosati J; Fiorillo A; Casamassa A; Vescovi AL; Giabbai B; Semrau MS; Fanelli S; Storici P; Squitieri F; Morea V; Ilari A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lentivirus-mediated shRNA targeting integrin-linked kinase on oral squamous cell carcinoma in vitro and in vivo.
    Que L; Zhao D; Tang XF; Liu JY; Zhang XY; Zhan YH; Zhang L
    Oncol Rep; 2016 Jan; 35(1):89-98. PubMed ID: 26531674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck.
    Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cell kinase as a nexus for drug repurposing: implications for cancer and HIV therapy.
    Almoyad MAA; Alsayari A; Wahab S; Chandra S
    J Biomol Struct Dyn; 2024 Mar; ():1-11. PubMed ID: 38529911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: a comparative docking and MD simulation studies.
    Gulzar M; Ali S; Khan FI; Khan P; Taneja P; Hassan MI
    J Biomol Struct Dyn; 2019 Oct; 37(16):4327-4337. PubMed ID: 30488773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer.
    Zheng CC; Hu HF; Hong P; Zhang QH; Xu WW; He QY; Li B
    Am J Cancer Res; 2019; 9(1):186-197. PubMed ID: 30755822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
    Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
    J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest.
    Cheng YW; Liao LD; Yang Q; Chen Y; Nie PJ; Zhang XJ; Xie JJ; Shan BE; Zhao LM; Xu LY; Li EM
    Cell Biochem Funct; 2018 Dec; 36(8):398-407. PubMed ID: 30484863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.
    Shirley LA; McCarty S; Yang MC; Saji M; Zhang X; Phay J; Ringel MD; Chen CS
    Surgery; 2016 Jan; 159(1):163-70. PubMed ID: 26549818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells.
    Chen Z; Yang A; Xu C; Xing Y; Gong W; Li J
    Graefes Arch Clin Exp Ophthalmol; 2011 Sep; 249(9):1399-407. PubMed ID: 21234586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.